Noticias - D.O.R.C. Dutch Ophthalmic Research Center |

Principal > Sala de prensa > Noticias

Volver a: pagina anterior

Artículos sobre últimas novedades

DORC announces strategic partnership with WEFIS GmbH for research and development of innovative ophthalmic instruments based on an equity investment — Thu 13 Jan 2022

DORC announces strategic partnership with WEFIS GmbH for research and development of innovative ophthalmic instruments based on an equity investment | Press Release

Zuidland, NETHERLANDS – DORC International and WEFIS GmbH are excited to announce a strategic partnership, based on an equity investment by DORC....

Leading a Global Leader, with Pierre Billardon — Mon 30 Aug 2021

Leading a Global Leader, with Pierre Billardon | Podcast by Ophthalmology Innovation Summit (USA)

"Dutch Ophthalmic Research Center (DORC) is a world-leading retinal surgical instrument developer....

Interview with Pierre Billardon, DORC CEO — Fri 9 Jul 2021

Interview with Pierre Billardon, DORC CEO | Ophthalmology Management, July 2021

In an interview with Ophthalmology Management magazine DORC CEO Pierre Billardon said he was satisfied with the 2020 results and expects...

DORC launches EVA EquiPhaco™ angled needles — Wed 16 Jun 2021

DORC launches EVA EquiPhaco™ angled needles | NEW

DORC introduces EVA EquiPhaco™ angled needles....

DORC launches new disposable phaco fragmentation needles — Fri 21 May 2021

DORC launches new disposable phaco fragmentation needles | NEW

DORC is pleased to introduce the new disposable phaco fragmentation needles in 20G and 23G to complement its existing range of reusable phaco...

DORC announces Health Canada approval of TissueBlue™ for Staining of the ILM During Vitreoretinal Surgery – the first Health Canada approved product for this indication. — Thu 28 Jan 2021

DORC announces Health Canada approval of TissueBlue™ for Staining of the ILM During Vitreoretinal Surgery – the first Health Canada approved product for this indication. | Press Release

DORC announces Health Canada approval of TissueBlue™ for Staining of the ILM During Vitreoretinal Surgery – the first Health Canada ap...

DORC launches new range of EVA EquiPhaco™ needles and sleeves — Mon 29 Jun 2020

DORC launches new range of EVA EquiPhaco™ needles and sleeves | new

DORC is excited to launch our new range of EVA EquiPhaco needles and sleeves. The EVA EquiPhaco™ range will deliver superior performance and ...

CEO statement on coronavirus — Fri 3 Apr 2020

CEO statement on coronavirus | COVID-19

The COVID-19 pandemic is having an unprecedented impact on our world, and clearly our first thoughts are with those people affected by this virus. ...

DORC at EURETINA 2019 — Mon 19 Aug 2019

DORC at EURETINA 2019 | INVITATION

Don't hesitate to join these exciting events - see you in Paris! ...

1 2 Siguiente